Such a validation and new training of the network may be, in particular, necessary for brain disorders which are known to affect the electrocorticogram and EEG including neurodegenerative (e.g., in different mouse models of Alzheimer's diseases; Kent et al., 2018), neurological (e.g., after striatal stroke in mice; Baumann et al., 2006), and neuropsychiatric conditions (e.g., SAPAP3-/- mice which are a model for anxiety and obsessive compulsive disorders; Lei et al., 2019). This evidence concerns the gene DLGAP3 and Alzheimer disease.